Australia markets close in 3 hours 18 minutes

Oventus Medical Limited (OVN.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1200+0.0050 (+4.35%)
As of 11:52AM AEDT. Market open.

Oventus Medical Limited

1 Swann Road
Suite 1 PO Box 190
Indooroopilly, QLD 4068
Australia
61 3 0053 3159
http://o2vent.com

Sector(s)Healthcare
IndustryMedical Devices
Full-time employees

Key executives

NameTitlePayExercisedYear born
Dr. Christopher Patrick HartCo-Founder, MD, CEO & Exec. Director868.84kN/AN/A
Mr. John CoxPres & COO517.49kN/AN/A
Mr. James HunterActing Chief Financial Officer202.85kN/AN/A
Dr. Stephen Denaro AGIA, BCom, GradDipApp CG, CA, MAICDCompany Sec.43.8kN/AN/A
Greg EatonVP SalesN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in AUD.

Description

Oventus Medical Limited, a medical device company, develops and commercializes oral appliances for the treatment of obstructive sleep apnoea (OSA) and snoring in Australia, Canada, and the United States. The company offers O2Vent Optima, a 3D-printed nylon oral appliance for OSA patients; and ExVent, a valve accessory that fits into the open airway of the O2Vent Optima device. The company was incorporated in 2015 and is headquartered in Indooroopilly, Australia.

Corporate governance

Oventus Medical Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.